Vancouver, British Columbia--(Newsfile Corp. - August 19, 2014) - OxySure Systems (OTCQB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions, with technology that rapidly generates medically pure oxygen by combining two inert powders, eliminating the need for storage in compressed tanks or other oxygen generators with their potential hazards, released its financial results for the quarter ending June 30, 2014.

InvestmentPitch.com has produced a "video news alert" which discusses this announcement. If this link is not enabled, please visit www.InvestmentPitch.com and enter "OxySure" in the search box.


If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_zbswiqn0/OxySure-Systems-OTCQB-OXYS-Released-its-financial-results-for-the-quarter-ending-June-30-2014

The OxySure Model 615 enables anyone, from bystanders to work colleagues, to administer medical oxygen easily and quickly in any medical emergency, while waiting for paramedics or first responders to arrive on the scene.

Total revenues for the 3 months ended June 30, 2014 were $678,000, an increase of approximately 42%, compared to $476,000 for the second quarter of 2013. This was the company's eighth consecutive quarter of double digit growth, with the increase primarily driven by an increase in product sales in the United States. Gross profit for the quarter was $413,000, an increase of approximately 28%, compared to $323,000 for the second quarter of 2013. Gross margins of 61%, were in line with previous periods.

Net loss for the 3 months came in at $320,000 for 2014, compared to a loss of $232,000 for the comparable quarter in 2013, an increase of $88,000 or 38%. The loss per share of $0.01 remained the same in both quarters.

OxySure achieved several milestones during the second quarter. In April, the company received CE Mark approval, a critical step toward launching this unique product into the 30 countries belonging to the European Economic Area. They announced a pilot program of a cloud based product tracking and incident reporting software system. The system, which also has a mobile application, is intended to allow the company's customers and distributors to track data associated with the OxySure Model 615 portable emergency oxygen device, and the replacement cartridges for the device.

They also announced that their products are now immediately available on mscdirect.com, to be followed by insertion in MSC Industrial's "Big Book". New York Stock Exchange-listed M, churches and placesSC  Industrial Direct is one of the largest distributors of Metalworking and Maintenance, Repair and Operations supplies to industrial customers throughout North America.

The OxySure Model 615 was launched into the K-12 educational market in the United States, and subsequently diversified into other institutional markets, such as colleges, churches and places of worship, manufacturing facilities and other commercial and municipal buildings.

Following the release of these numbers, Taglich Brothers re-iterated their speculative buy recommendation and 12 month price target of $2.10. The company is trading at $0.75, and with 26 million shares outstanding, the company is capitalized at $19.5 million.

For more information about OxySure, please visit the company's website www.oxysure.com.

Investor relations is handled by Stonegate Securities, which can be reached at 214-987-4121 or by email at investors@oxysure.com, with Canadian investor relations handled by Renmark Financial www.renmarkfinancial.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases, research reports and other market information. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
604-684-5524
bmorgan@investmentpitch.com